⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2767496 | 0.86 | KDM4E (0.38) | — | |
| SCHEMBL2767967 | 0.84 | DPP4 (0.38) | — | |
| SCHEMBL225342 | 0.80 | — | — | |
| SCHEMBL45854 | 0.80 | — | — | |
| SCHEMBL155145 | 0.78 | TDP1 (0.40) | — | |
| SCHEMBL1414863 | 0.78 | KDM4E (0.45) | — | |
| SCHEMBL13049960 | 0.78 | KDM4E (0.45) | — | |
| SCHEMBL3870601 | 0.77 | KDM4E (0.42) | — | |
| SCHEMBL13873989 | 0.76 | — | — | |
| SCHEMBL1522719 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112920813-B | Photo-thermal response chiral photosensitive liquid crystal dopant containing azobenzene binaphthyl | 湘潭大学 | 2023-08-22 | — | — | CN | claimed |
| CN-112920813-A | Photo-thermal responsive chiral photosensitive liquid crystal dopant containing azobenzene binaphthalene | 湘潭大学 | 2021-06-08 | — | — | CN | claimed |
| CN-102574857-B | Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors | LEO PHARMA AS | 2015-06-10 | — | — | CN | claimed |
| US-20260062443-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMA INC (US) | 2026-03-05 | — | — | US | disclosed |
| WO-2024044098-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024044098-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-11807644-B2 | Methods and compounds for restoring mutant p53 function | PMV PHARMACEUTICALS, INC. (US) | 2023-11-07 | — | — | US | disclosed |
| WO-2023205701-A1 | MACROCYCLIC HETEROCYCLES AND USES THEREOF | KUMQUAT BIOSCIENCES INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20230295137-A1 | COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOF | DANA FARBER CANCER INST INC (US) | 2023-09-21 | — | — | US | disclosed |
| CN-112920813-B | Photo-thermal response chiral photosensitive liquid crystal dopant containing azobenzene binaphthyl | 湘潭大学 | 2023-08-22 | — | — | CN | disclosed |
| US-20230183286-A1 | NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA | NOVARTIS AG (CH) | 2023-06-15 | — | — | US | disclosed |
| US-7169786-B2 | Isoxazoline derivatives as anti-depressants | JANSSEN-CILAG S.A. (ES) | 2007-01-30 | — | — | US | disclosed |
| EP-1188747-B1 | PHENOXYPROPYLAMINE COMPOUNDS | MITSUBISHI PHARMA CORP (JP) | 2005-09-07 | — | — | EP | disclosed |
| US-20050153167-A1 | repeating units of arylene groups, divalent heterocyclic groups and divalent aromatic amine groups, and end group(s) of, a monovalent heterocyclic group optionally coordinated to form a metal complex, and an aromatic end group, fluorescence in the solid state, high molecular weight, excellent properties | SUMITOMO CHEMICAL COMPANY, LIMITED | 2005-07-14 | — | — | US | disclosed |
| CN-1164574-C | Phenoxypropylamine compounds | ������ҩ��ʽ���� | 2004-09-01 | — | — | CN | disclosed |
| US-20040138227-A1 | Phenoxypropylamine compounds | NISHIYAMA AKIRA | 2004-07-15 | — | — | US | disclosed |
| US-6720320-B2 | ANTISEROTONINE AGENTS | MITSUBISHI PHARMA CORPORATION (JP) | 2004-04-13 | — | — | US | disclosed |
| CN-1378533-A | Phenoxypropylamine compounds | MITSUBISHI PHARMACEUTICAL CO L (JP) | 2002-11-06 | — | — | CN | disclosed |
| US-20020111358-A1 | Phenoxypropylamine compounds | MITSUBISHI PHARMA CORPORATION (JP) | 2002-08-15 | — | — | US | disclosed |
| EP-1188747-A1 | PHENOXYPROPYLAMINE COMPOUNDS | Mitsubishi Pharma Corporation (JP) | 2002-03-20 | — | — | EP | disclosed |